• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
...

Request the impact of COVID-19 in this market at no additional cost. Buy it today to get an advantage.

Request Now


The global home healthcare device industry has experienced good growth over the last five years and is expected to reach approximately US $29 billion in 2017 with a CAGR of 3% over the next five years.

Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the global home health care device companies and presents its findings in “Top Five Global Home Healthcare Device Companies: Performance, Strategies, and Competitive Analysis.” The report provides detailed insight into the performance of the top five home health care device companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of the companies covered.

The home healthcare device industry comprises manufacturers of blood pressure monitors, glucose monitors, diabetics control devices, wheelchairs, walking aids, oxygen inhalers, thermometers and other devices. The industry is consolidated. In this study, Lucintel thoroughly profiles the following five companies with detailed competitive assessments:
  • Abbott Laboratories            
  • Invacare Corporation        
  • Johnson & Johnson        
  • 3M                
  • Philips                                               
Firms that provide home healthcare devices are approaching market opportunities with starkly different strategies. Lucintel’s research indicates that although Asia Pacific (APAC) is a smaller market, it holds good growth potential for the future due to the growing middle class population throughout Asia, especially in China, India, and Southeast Asia. In North America, small family units and a large huge dependent aging population are expected to drive the growth in the home health care device industry over the forecast period.

This study provides industry leaders with a competitive benchmarking of the world’s top five home healthcare device companies. The study provides up-to-date information on the market share, profit margins, capabilities, and strategies of the leaders. The report helps current suppliers realistically assess their industry standing vis-a-vis leading competitors. It is designed to provide executives with strategically significant competitor information, data analysis, and insight, critical to the development and implementation of effective marketing and sales plans.

Healthcare device companies competitive analysis report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global home healthcare device companies. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business.

In Lucintel's newest competitive research study on the world's home healthcare device companies, we thoroughly profile following five companies with detailed competitive assessments:
  • Abbott Laboratories            
  • Invacare Corporation        
  • Johnson & Johnson        
  • 3M                
  • Philips                           
The detailed analysis of each company offers a critical view into key strategic areas, including:
  • Company overview          
  • Benchmarking (financial & market)
  • SWOT analysis         
  • Product positioning
  • Marketing strategy and tactics    
  • Corporate strategy
To make any investment, business or strategic decisions, you need adequate and timely information. Healthcare device companies competitive analysis market report fulfills this core need. This is an indispensable reference guide for industry executives who are dealing with home healthcare device companies industry. 

Some of the features of Top Five Global Home Healthcare Device Companies: Performance, Strategies, and Competitive Analysis market intelligence report are:
 
  • Market size estimates in terms of (US $) value by segments of the global home healthcare device companies
  • Regional analysis: global home healthcare device companies breakdown by key regions (e.g., North America, Europe, APAC and ROW)
  • Healthcare device market trends, drivers and forecasts
  • Competitive benchmarking of each players against their financial & market strength
  • Global and regional market share estimates for the top players
  • Product line overview and positioning of top players
  • SWOT analysis of the leaders
  • Marketing strategy and tactics    
  • Corporate strategy
  • More than 113 valuable figures/charts and 45 tables are provided in this report
     
 1. Executive Summary  

 2. Market Definition and Scope  

 3. Market Opportunity  

 4. Competitive Benchmarking (Financial and Market)  

 5. Company Profile on Following Parameters  

 6. Profiles on Following Companies  
 6.1. Abbott Laboratories  
 6.2. Invacare Corporation  
 6.3. Johnson & Johnson  
 6.4. 3M  
 6.2. Philips  

List of Figures
 
CHAPTER 3. Market Opportunity
             Figure 3.1: Supply chain for pesticide market
Figure 3.2: Global pesticide industry annual trend 2006-2011 (US $B)
Figure 3.3: Global pesticide industry regional trend 2006-2011 (US $B)
Figure 3.4: Global pesticide industry regional trend 2006-2011 (%)
Figure 3.5: Global pesticide industry segment trend 2006-2011 (US $B)
Figure 3.6: Global pesticide industry segment trend 2006-2011 (%)
Figure 3.7: Global pesticide industry opportunity by region
Figure 3.8: Global pesticide industry opportunity by segment
    
CHAPTER 4.Competitive Benchmarking (Financial and Market)
Figure 4.1: Top five pesticide companies – financial benchmarking
Figure 4.2: Global top five pesticide companies gross profit and net profit analysis – 2011
Figure 4.3: Financial analysis – growth leadership quadrant (2011)
Figure 4.4: Market share of top players 2006
Figure 4.5: Market share of top players 2011
Figure 4.6: 2006 Market share analysis
Figure 4.7: 2011 Market share analysis
Figure 4.8: Global market share analysis 2011
Figure 4.9: Global market fragmentation 2011  
Figure 4.10: Market value North America (US $B)
Figure 4.11: Market value Europe (US $B)
Figure 4.12: Market value Asia Pacific (US $B)
Figure 4.13: Market value Row: (US $B)
Figure 4.14: Regional revenue evaluation 2011(US $M)
Figure 4.15: Regional revenue evaluation 2011(%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top five major players
 
CHAPTER 5. Company Profile of Abbott Laboratories
Figure 5.1: Abbott Laboratories revenue by business structure 2011
Figure 5.2: Lucintel Triad – Abbott Laboratories
Figure 5.3: Financial benchmarking Abbott Laboratories against top three and top five industry players’ average
Figure 5.4: Financial benchmarking of Abbott Laboratories against Top Five best
Figure 5.5: Global industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 5.6: Global market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.8: European industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.9:   APAC industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.10: ROW industry revenue trend Vs Abbott Laboratories 2007-2011 in (US $B)
Figure 5.11: North American market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.12: European market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.13: APAC market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.14: ROW market share trend Vs Abbott Laboratories 2007-2011 in (%)
Figure 5.15: Abbott Laboratories productivity: 2007-2011 in (US $B)
Figure 5.16: Abbott Laboratories fixed asset value: 2007-2011 in (US $B)
Figure 5.17: Strategic execution
 
CHAPTER 6. Company Profile of Invacare Corporation
Figure 6.1: Invacare Corporation. revenue by business structure 2011
Figure 6.2: Lucintel triad - Invacare Corporation
Figure 6.3: Financial benchmarking of Invacare Corporation. against top three and top five industry players’ average
Figure 6.4: Financial benchmarking of Invacare Corporation against Top five best
Figure 6.5: Global industry revenue trend Vs Invacare Corporation (2007-2011) in (US $B)
Figure 6.6: Global market share trend for Invacare Corporation. (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs Invacare Corporation (2007-2011 in (US $B)
Figure 6.8: European industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.9: APAC industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.10: ROW industry revenue trend Vs Invacare Corporation 2007-2011 in (US $B)
Figure 6.11: North American market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.12: European market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.13: APAC market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.14: ROW market share trend Vs Invacare Corporation 2007-2011 in (%)
Figure 6.15: Invacare Corporation productivity: 2007-2011 in (US $B)
Figure 6.16: Invacare Corporation fixed asset value: 2007-2011 in (US $B)
Figure 6.17: Strategic execution
 
CHAPTER 7. Company Profile of Johnson & Johnson
Figure 7.1: Johnson & Johnson revenue by business structure 2011
Figure 7.2: Lucintel triad – Johnson & Johnson
Figure 7.3: Financial benchmarking of Johnson & Johnson against top three and top five industry players’ average
Figure 7.4: Financial benchmarking of Johnson & Johnson against Top five best
Figure 7.5: Global industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.6: Global market share trend for Johnson & Johnson (2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.8: European industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.9: APAC industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.10: ROW industry revenue trend Vs Johnson & Johnson (2007-2011) in (US $B)
Figure 7.11: North American market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.12: European market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.13: APAC market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.14: ROW market share trend Vs Johnson & Johnson (2007-2011) in (%)
Figure 7.15: Johnson & Johnson productivity: 2007-2011 in (US $B)
Figure 7.16: Johnson & Johnson fixed asset value: 2007-2011 in (US $B)
Figure 7.17: Strategic execution
 
CHAPTER 8. Company Profile of 3M
Figure 8.1: 3M revenue by business structure 2011
Figure 8.2: Lucintel triad – 3M
Figure 8.3: Financial benchmarking of 3M against top three and top five industry players
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Top Five Global Home Healthcare Device Companies: Performance, Strategies, and Competitive Analysis, Full Report $ 1,980
More than 113 valuable figures/charts and 45 tables are provided in this report
 
Lucintel has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets / applications and served 1,000+ clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data
  • Extensive search of published works, market and database information with industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted in the supply chain of this market to estimate market share, market size, trends, drivers, challenges and forecasts in the market. Below is a brief summary of primary interviews conducted by both job function and region.


Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis on it. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of the Lucintel research process.

 

Please sign in below to get report brochure - Top Five Global Home Healthcare Device Companies.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )